机构

• 上海药物研究所 [18]
• 昆明植物研究所 [12]
• 心理研究所 [11]
• 近代物理研究所 [10]
• 国家天文台 [9]
• 武汉病毒研究所 [6]
• 更多

采集方式

• OAI收割 [107]
• iSwitch采集 [8]

内容类型

• 期刊论文 [115]

发表日期

• 2024 [2]
• 2023 [6]
• 2022 [3]
• 2021 [20]
• 2020 [3]
• 2019 [8]
• 更多

学科主题

• Plant Scie... [4]
• Physics [3]
• Cardiovasc... [2]
• Chemistry,... [2]
• Hematology [2]
• Pharmacolo... [2]
• 更多

筛选

浏览/检索结果: 共115条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 π-HuB: the proteomic navigator of the human body 期刊论文  OAI收割 NATURE, 2024, 卷号: 636, 期号: 8042, 页码: 322-331 作者:  He, Fuchu;  Aebersold, Ruedi;  Baker, Mark S.;  Bian, Xiuwu;  Bo, Xiaochen   |  收藏  |  浏览/下载：12/0  |  提交时间：2025/04/01 Transcriptomic decoding of regional cortical vulnerability to major depressive disorder 期刊论文  OAI收割 COMMUNICATIONS BIOLOGY, 2024, 卷号: 7, 期号: 1, 页码: 12 作者:  Zhu, Jiajia;  Chen, Xiao;  Lu, Bin;  Li, Xue-Ying;  Wang, Zi-Han   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/09/10 Prevalence and factors associated with frailty and pre-frailty in the older adults in China: a national cross-sectional study 期刊论文  OAI收割 FRONTIERS IN PUBLIC HEALTH, 2023, 卷号: 11, 页码: 15 作者:  Zeng, Xue-zhai;  Meng, Ling-bing;  Li, Ying-ying;  Jia, Na;  Shi, Jing   |  收藏  |  浏览/下载：30/0  |  提交时间：2023/10/09 China  older adults  frailty  pre-frailty  prevalence   Prevalence of frailty and pre-frailty and related factors in older adults with cardio-cerebral vascular disease in China: a national cross-sectional study 期刊论文  OAI收割 FRONTIERS IN PUBLIC HEALTH, 2023, 卷号: 11, 页码: 11 作者:  Zeng, Xue-zhai;  Meng, Ling-bing;  Jia, Na;  Shi, Jing;  Zhang, Chi   |  收藏  |  浏览/下载：25/0  |  提交时间：2023/10/09 cardio-cerebral vascular disease  China  frailty  older adults  pre-frailty  prevalence   Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 9 作者:  Li, Hua-ying;  Chen, Yi-li;  Deng, Xiang-nan;  Li, Huan-huan;  Tan, Jie   |  收藏  |  浏览/下载：43/0  |  提交时间：2023/10/17 cancer immunotherapy  B7-H3  PD-L1  bispecific antibodies  VHH  antibody-dependent cell-mediated cytotoxicity (ADCC)   Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance 期刊论文  OAI收割 EMBO MOLECULAR MEDICINE, 2023, 页码: 24 作者:  Wang, Li-Min;  Wang, Pingyuan;  Chen, Xiao-Min;  Yang, Hui;  Song, Shan-Shan   |  收藏  |  浏览/下载：51/0  |  提交时间：2023/04/10 homologous recombination repair  olaparib-resistant  PARP inhibitor  PARP7  type I interferons   A study on the prevalence and related factors of frailty and pre-frailty in the older population with hypertension in China: A national cross-sectional study 期刊论文  OAI收割 FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 卷号: 9, 页码: 13 作者:  Zeng, Xue-zhai;  Jia, Na;  Meng, Ling-bing;  Shi, Jing;  Li, Ying-ying   |  收藏  |  浏览/下载：47/0  |  提交时间：2023/02/27 older adults  hypertension  frailty  pre-frailty  related factors  prevalence   Labdane diterpenoids from the heartwood of Leucosceptrum canum that impact on root growth and seed germination of Arabidopsis thaliana 期刊论文  OAI收割 PHYTOCHEMISTRY, 2023, 卷号: 206, 页码: 113531 作者:  Liu,Yan;  Zhou,Yan-Ying;  Luo,Shi-Hong;  Guo,Kai;  Zhang,Man-Wen   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/07/22 Leucosceptrum canum  Lamiaceae  Labdane diterpenoids  Leucolactones A-K  Phytotoxic activity  Auxin accumulation  GLANDULAR TRICHOMES  COLORED NECTAR  AUXIN  TRANSPORT  GRADIENT  WOOD   Reduced nucleus accumbens functional connectivity in reward network and default mode network in patients with recurrent major depressive disorder 期刊论文  OAI收割 TRANSLATIONAL PSYCHIATRY, 2022, 卷号: 12, 期号: 1, 页码: 9 作者:  Ding, Yu-Dan;  Chen, Xiao;  Chen, Zuo-Bing;  Li, Le;  Li, Xue-Ying   |  收藏  |  浏览/下载：86/0  |  提交时间：2022/07/18 Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 9 作者:  Qian, Hong-jie;  Wang, Yu;  Zhang, Meng-qi;  Xie, Yuan-chao;  Wu, Qing-qing   |  收藏  |  浏览/下载：58/0  |  提交时间：2022/06/15 VV116  nucleoside analog  SARS-CoV-2  safety  pharmacokinetics  healthy subjects